Mission
To focus on addressing scientific challenges in CNS drug development, through research and collaboration among stakeholders including academia, industry and government.
Public Charity
INTERNATIONAL SOCIETY FOR CNS DRUG DEVELOPMENT
INTERNATIONAL SOCIETY FOR CNS DRUG DEVELOPMENT is a nonprofit organization categorized as Public Charity based in SAN DIEGO, CA. Its most recent IRS filing (2025) reports revenue of $597K, expenses of $492K, total assets of $2.1M.
EIN: 030457495
SAN DIEGO, CA
Latest filing: 2025
Total Revenue$597K
Total Expenses$492K
Total Assets$2.1M
Grant Records0
Filing Years2021–2025
Officers & Directors
CFO/SECRETARY
Amir Kalali
Chairman
Bill Martin
Director
David Daniel
Officer compensation and complete director data available with membership.
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $597K | $492K | $2.1M |
| 2024 | $332K | $340K | $714K |
| 2023 | $338K | $366K | $702K |
| 2022 | $265K | $325K | $732K |
| 2021 | $237K | $218K | $790K |
Between 2021 and 2025, reported annual revenue grew from $237K to $597K (+152%), with total assets most recently reported at $2.1M.
Interactive year-over-year charts and full filing details available with membership.